Short-term outpatient follow-up of vericiguat treatment in patients hospitalized for heart failure
Vericiguat is feasible in acute HF, even in patients with hypotension and renal dysfunction. At the same time, vericiguat may have a potential renoprotective effect, which warrants further exploration.
Authors
- Zihan Li (ORCID: https://orcid.org/0009-0008-4765-8244)
- Daoyuan Si
- Tingxun Liu (ORCID: https://orcid.org/0009-0005-7113-0018)
- Tingting Li
- Ping Yang (ORCID: https://orcid.org/0000-0002-0811-7989)
- Yuquan He (ORCID: https://orcid.org/0000-0001-5662-2990)
- Yuanqiao Liu
Institutions
- Jilin University (CN)
- Union Hospital (CN)
Publication Details
- Journal
- Frontiers in Cardiovascular Medicine
- Published
- 2025-03-04
- DOI
- https://doi.org/10.3389/fcvm.2025.1465700
- Primary Topic
- Heart Failure Treatment and Management
- Type
- article
- Field-Weighted Citation Impact
- 0.00